Literature DB >> 7625767

Cladistic analysis of the apolipoprotein AI-CIII-AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis.

M B Haviland1, A M Kessling, J Davignon, C F Sing.   

Abstract

A cladistic analysis was carried out to identify haplotypes hypothesized to differ for functional DNA sequence variations within the apolipoprotein (apo) AI-CIII-AIV gene cluster that affect plasma lipid, lipoprotein and apolipoprotein levels. A sample of unrelated healthy French Canadians was studied. First, a cladogram of the observed apo AI-CIII-AIV haplotypes was estimated. Then this cladogram was used to define a statistical analysis of the association between haplotype variation and variation in plasma lipid, lipoprotein and apolipoprotein levels. Three haplotypes were identified which were associated with small (5-12% of the total sum of squares) pleiotropic effects on plasma lipid, lipoprotein and apolipoprotein traits and these effects were context, i.e. gender, dependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625767     DOI: 10.1111/j.1469-1809.1995.tb00742.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  3 in total

1.  A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.

Authors:  Lue Ping Zhao; Shuying Sue Li; Najma Khalid
Journal:  Am J Hum Genet       Date:  2003-04-16       Impact factor: 11.025

2.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

3.  On the use of haplotype phylogeny to detect disease susceptibility loci.

Authors:  Claire Bardel; Vincent Danjean; Jean-Pierre Hugot; Pierre Darlu; Emmanuelle Génin
Journal:  BMC Genet       Date:  2005-05-18       Impact factor: 2.797

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.